Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Testicular cancer incidence predictions in Europe 2010–2035: A rising burden despite population ageing

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Tibolone and risk of gynecological hormone sensitive cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Does HPV status influence survival after vulvar cancer?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Use of nonaspirin nonsteroidal anti-inflammatory drugs and risk of head and neck cancer: A nationwide case-control study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Prevalence, type distribution, and risk factors for oral HPV in Danish renal transplant recipients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Human papillomavirus vaccination in immigrants and descendants of immigrants in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Ana Babic
  • Holly R Harris
  • Allison F Vitonis
  • Linda J Titus
  • Susan J Jordan
  • Penelope M Webb
  • Harvey A Risch
  • Mary Anne Rossing
  • Jennifer A Doherty
  • Kristine Wicklund
  • Marc T Goodman
  • Francesmary Modugno
  • Kirsten B Moysich
  • Roberta B Ness
  • Susanne K Kjaer
  • Joellen Schildkraut
  • Andrew Berchuck
  • Celeste L Pearce
  • Anna H Wu
  • Daniel W Cramer
  • Kathryn L Terry
  • Australian Ovarian Cancer Study Group
Vis graf over relationer

Menstrual pain, a common gynecological condition, has been associated with increased risk of ovarian cancer in some, but not all studies. Furthermore, potential variations in the association between menstrual pain and ovarian cancer by histologic subtype have not been adequately evaluated due to lack of power. We assessed menstrual pain using either direct questions about having experienced menstrual pain, or indirect questions about menstrual pain as indication for use of hormones or medications. We used multivariate logistic regression to calculate the odds ratio (OR) for the association between severe menstrual pain and ovarian cancer, adjusting for potential confounders and multinomial logistic regression to calculate ORs for specific histologic subtypes. We observed no association between ovarian cancer and menstrual pain assessed by indirect questions. Among studies using direct question, severe pain was associated with a small but significant increase in overall risk of ovarian cancer (OR = 1.07, 95% CI: 1.01-1.13), after adjusting for endometriosis and other potential confounders. The association appeared to be more relevant for clear cell (OR = 1.48, 95% CI: 1.10-1.99) and serous borderline (OR = 1.31, 95% CI: 1.05-1.63) subtypes. In this large international pooled analysis of case-control studies, we observed a small increase in risk of ovarian cancer for women reporting severe menstrual pain. While we observed an increased ovarian cancer risk with severe menstrual pain, the possibility of recall bias and undiagnosed endometriosis cannot be excluded. Future validation in prospective studies with detailed information on endometriosis is needed.

OriginalsprogEngelsk
TidsskriftRadiation Oncology Investigations
Vol/bind142
Udgave nummer3
Sider (fra-til)460-469
Antal sider10
ISSN0020-7136
DOI
StatusUdgivet - 1 feb. 2018

ID: 52396773